01
Fragmented information
Market access work still begins in old decks, spreadsheets, public links, conference notes, local advice, and assumptions no one has clearly reviewed.
About GHMAP
Why GHMAP Exists
GHMAP exists because global healthcare commerce still depends on fragmented information, disconnected relationships, and decisions made before reviewed evidence is visible.
Why GHMAP exists
A trust-first operating layer for healthcare market access — source status and review needs stay visible.
The category
The global trust layer for healthcare commerce.
Not another directory. Not another CRM. Infrastructure for reviewed intelligence, connected relationships, and structured execution before innovation moves across markets.
GHMAP does not replace clinical, legal, regulatory, reimbursement, or investment review. It exists to make source status, relationship context, and professional review needs visible before serious teams act.
The problem
The world before GHMAP is not short on ambition. It is short on coordinated market-access infrastructure.
Healthcare companies want to reach new markets. Hospitals want better products. Clinicians want responsible innovation. Investors want clearer risk. Distributors want credible partners. The work connecting them is still scattered across people, inboxes, assumptions, and unverified context.
02
Disconnected stakeholders
Manufacturers, hospitals, clinicians, distributors, investors, and operators each hold part of the context, but rarely work from the same reviewed operating view.
03
Regulatory uncertainty
Pathway questions, source dates, evidence gaps, and professional review needs often stay unclear until a team has already committed time and capital.
04
Lack of qualified relationships
Healthcare commerce cannot run on anonymous outreach. It depends on credible people, accountable context, and relationships supported by both.
05
Duplicated effort
Teams repeat the same discovery because prior findings, blockers, reviewers, introductions, and next actions are not preserved in one operating layer.
06
Expensive market-entry mistakes
A weak country assumption, wrong partner fit, or missing review step can turn promising innovation into avoidable delay before patients ever benefit.
The pattern
The same failure kept appearing: good healthcare opportunities could not move cleanly through global systems.
A manufacturer would have a promising product but unclear country readiness. A hospital or clinician could see value but lacked structured commercial context. A distributor conversation might start with energy but little verification. An investor could see potential but not the evidence trail. The issue was rarely one missing document. It was the absence of coordinated evidence and relationship context.
Existing tools treated the work as contacts, files, or tasks. Healthcare market access needs relationship context, evidence status, and professional accountability in the same operating view.
The cost of fragmentation is not only commercial. Every delayed partnership, incorrect assumption, and failed market entry can delay patient access to useful healthcare innovation.
GHMAP became necessary because global collaboration needs structure before transactions begin.
New category
Accountable infrastructure for global healthcare commerce.
GHMAP is the infrastructure layer between scattered market-access knowledge and responsible healthcare execution. It organizes what must be verified or reviewed before a product, partnership, country launch, hospital evaluation, distributor conversation, or investment question moves forward.
The mission is not to make healthcare more automated for its own sake. The mission is to make global healthcare collaboration more accountable, more transparent, and less dependent on fragile informal systems.
Evidence
Sources and review status before reliance.
Relationships
People connected to role, context, and project need.
Execution
Next actions and blockers made visible.
Founder
The founder story is the mission story.
GHMAP is not built around a personal biography. It is built around a recurring problem: healthcare innovation depends on credible evidence and accountable relationships, but the systems used to coordinate them across countries are still fragmented, informal, and difficult to verify.
Dr. Cengiz Yentur founded GHMAP to turn that problem into infrastructure: relationships with context, intelligence with source status, and collaboration with professional responsibility.
Founder
Dr. Cengiz Yentur
Founder & CEO, GHMAP
GHMAP exists because global healthcare should not depend on disconnected spreadsheets, cold introductions, unreviewed assumptions, or memory. The mission is to build a structured operating layer for the people and organizations trying to move healthcare innovation responsibly across markets.
Mission
Build the global trust layer for healthcare commerce.
Vision
Before GHMAP, healthcare commerce is fragmented. After GHMAP, evidence and relationships become coordinated infrastructure.
Before GHMAP
- Market context scattered across spreadsheets, emails, conference conversations, and private notes.
- Relationships remembered by individuals instead of structured around project, role, country, and product context.
- Regulatory and reimbursement questions treated as informal assumptions until late in the process.
- Teams moving forward without a shared view of source status, review needs, or next action.
After GHMAP
- Qualified relationships connected to the healthcare work they are meant to support.
- Structured execution across manufacturers, clinicians, hospitals, distributors, investors, and operators.
- Reviewed intelligence with source status, evidence gaps, confidence, and professional review clearly visible.
- Transparent collaboration where serious teams can see what is known, what is missing, and who should act next.
Fragmented healthcare work
Information, relationships, meetings, and decisions sit in disconnected systems.
Reviewed relationship context
People and organizations are connected with role, country, product, project, and accountability.
Reviewed intelligence
Sources, evidence gaps, confidence, and review status are visible before reliance.
Global collaboration
Cross-border teams coordinate around shared projects, not scattered messages.
Accountable market-access infrastructure
Healthcare commerce gains infrastructure for evidence-led, relationship-aware collaboration.
Core principles
Principles that keep the platform grounded.
Six commitments that decide what ships, what gets marked reviewed, and what GHMAP declines to claim.
Review before transactions.
Evidence before decisions.
People before products.
Transparency over assumptions.
Global collaboration.
Professional responsibility.
Different by design
GHMAP is not another SaaS category dressed in healthcare language.
A directory can list people. A CRM can track activity. A database can store information. Global healthcare commerce needs the layer beneath execution: evidence, qualified relationships, review, and accountability connected in one place.
Traditional platforms
GHMAP
Directory
Global trust layer
Static database
Living intelligence
Unverified contacts
Reviewed relationship context
Documents
Structured execution
Information
Accountable collaboration
What success looks like
Success is not measured by software usage alone.
The important measure is whether global healthcare collaboration becomes more accountable and less wasteful.
Qualified collaboration between relevant healthcare stakeholders.
Faster market-access work because context and next actions are visible earlier.
Stronger healthcare partnerships built from reviewed relationship context, not cold lists.
Safer commercialization because source gaps and review needs are clear before reliance.
More patients accessing healthcare innovation because fewer good opportunities fail from preventable fragmentation.
Long-term mission
One of global healthcare's hardest infrastructure problems is not discovery. It is trust.
Healthcare innovation often fails to reach the right markets because qualified relationships, reviewed intelligence, and execution context are not connected early enough. GHMAP exists to reduce those failures by making that operating context visible before teams commit time, money, reputation, and products.
This is why GHMAP is infrastructure, not just software: it is an attempt to give global healthcare commerce a more reliable foundation. It does not replace clinical, legal, regulatory, reimbursement, or investment review.
Early work
Early work, real markets.
Country Intelligence delivered for wound-care companies evaluating entry into African markets. Names and quotes are published with each company's written permission.
Wound care · African market evaluation
MDM Wound Ventures
Country Intelligence supporting market-entry assessment across West and East African markets, including Mali, Kenya and Nigeria.
“The GHMAP brief gave us a clear, evidence-based read on regulatory and distributor realities in West Africa before we committed our commercial budget. It is a critical tool for any MedTech team evaluating new markets.”
Advanced wound care · International distribution planning
MELYVERA
Country Intelligence for a professional wound-care range preparing for international distribution, with focus markets in Africa.
“GHMAP provided the structured roadmap we needed to navigate international distribution for our advanced wound-care range. The source-tagged intelligence removed the guesswork from our expansion strategy.”
Start with reviewed context
Ready to build stronger healthcare partnerships on accountable infrastructure?
Start with project context, role fit, source status, and professional review needs before market-access work becomes expensive to correct.
Professional review is required before business use.